Serum Institute India Seeks Emergency Use Nod For Covishield
New Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield.
"As promised, before the end of 2020, @SerumInstIndia has applied for emergency use…
Read More...
Read More...